More on PMVP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PMV Pharmaceuticals (NQ:PMVP)
Delayed: 1.64 +0.11 (7.19%)
Prev. Close $1.53  
Open$1.63 
52 Wk High$ 
52 Wk Low$ 
Day High$1.69 
Day Low$1.58 
P/E N/A  
EPS$ 
Volume1,080,025 


Mar 6, 2026 09:23 AM Form S-8 PMV Pharmaceuticals,
Mar 6, 2026 08:25 AM Form 8-K PMV Pharmaceuticals, For: Mar 06
Mar 6, 2026 08:02 AM Form 10-K PMV Pharmaceuticals, For: Dec 31
Mar 6, 2026 08:00 AM PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Mar 4, 2026 09:12 PM Form SCHEDULE 13D/A PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 26, 2026 08:01 AM PMV Pharmaceuticals rezatapopt study published in medical journal
Feb 26, 2026 08:00 AM New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Feb 17, 2026 04:38 PM Form SCHEDULE 13G/A PMV Pharmaceuticals, Filed by: ArrowMark Colorado Holdings LLC
Feb 9, 2026 02:19 PM Form SCHEDULE 13G/A PMV Pharmaceuticals, Filed by: BML Investment Partners, L.P.
Nov 13, 2025 09:16 AM PMV Pharmaceuticals Inc. (PMVP) PT Lowered to $4 at Craig-Hallum
View All Articles

Entities mentioned with PMVP

View All Entities